REDCap Central is now available for Clinical and Translational Science Awards multi-center trials. This new Trial Innovation Network resource offers the CTSA Consortium a cost-effective option if they have a study that is an FDA-regulated Clinical Trial, Investigational New Drug (IND) trial or Investigational Device Exemption (IDE) trial. VUMC’s REDCap Central is centrally managed and fully validated – including audit trails and change control – so that research teams can focus on project-level compliance such as protocol validation, documentation, and training.

Speaker is Paul Harris, a professor of Biomedical Informatics with secondary appointments in Biostatistics and Biomedical Engineering of Vanderbilt University Medical Center and a director of a TIN Recruitment Innovation Center.

This event, hosted by the Trial Innovation Network, is made available to the University of Rochester community via the UR Clinical and Translational Science Institute.